Brief: Carsgen Therapeutics Says FY Net Loss RMB4.74 Bln Vs Loss Of RMB1.06 Bln
22/03/2022 14:48
March 22 (Reuters) - CARsgen Therapeutics Holdings Ltd
2171.HK :
* FY NET LOSS RMB4.74 BILLION VERSUS LOSS OF RMB1.06 BILLION
Source text for Eikon: ID:nHKS1jB5N5
Further company coverage: 2171.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CARsgen Therapeutics Holdings
See all newsBrief: Carsgen Therapeutics Says CT1190B Receives IND Clearance From NMPA For Relapsed/Refractory Large B-Cell Lymphoma
Brief: Carsgen Therapeutics Says CT0596 Receives IND Clearance From NMPA
Brief: Carsgen Therapeutics Approves Share Repurchase Plan For Up To 30.12 Million Shares
CARsgen Therapeutics climbs on board nod for share buyback
Brief: Carsgen Therapeutics Says NMPA Approves Satricabtagene Autoleucel For Advanced Gastric Cancer